Home Tianwu Technology Wins Bronze Award at 'Haiju Yingcai' Global Innovation and Entrepreneurship Competition

Tianwu Technology Wins Bronze Award at 'Haiju Yingcai' Global Innovation and Entrepreneurship Competition

Nov 27, 2025 11:03 CST Updated 11:03
Matwings Technology

AI Protein Design Service Provider

Image
Click the blue words above to follow us
Image
Image
Abstract

Image

On November 25, the 5th "Gathering Talents in Shanghai" Global Innovation and Entrepreneurship Summit grandly opened at the West Bund International Convention Center in Shanghai. Chen Jining, Secretary of the Shanghai Municipal Committee, attended the opening ceremony and launched the 6th Global Innovation and Entrepreneurship Competition. The winners of the 5th competition were announced on-site at the summit. Matwings Technology, a portfolio company of Pinellia Capital, stood out with its project "Protein Function Design Driven by Large AI Models," winning the Bronze Gathering Award. This achievement fully demonstrates the company's original technical strength and industrial application potential in the crossover field of large AI models and biomanufacturing.

图片

The "Haiju Yingcai" Global Innovation and Entrepreneurship Competition, as the highest-level talent event in Shanghai, has always been highly anticipated. The Fifth "Haiju Yingcai" Global Innovation and Entrepreneurship Competition collected 14,723 projects globally. After rounds of fierce competition and rigorous evaluation, 60 outstanding projects stood out — with six winning the Gold Award, 18 the Silver Award, and 36 the Bronze Award, covering fields such as hardcore technology and artificial intelligence. The overall award-winning rate was only 0.4%. Matwings TechnologyThis award is another significant reflection of the team's deep accumulation in the field of AI protein design and green biomanufacturing.

Protein function is the key to realizing its commercialization and the core of industrial transformation.To tackle this challenge, Matwings Technology has built a dedicated protein dataset containing nearly 9 billion sequences.This dataset not only covers conventional biological protein sequences but also integrates special functional sequences with high temperature resistance, acid and alkali resistance, and others from extreme environments such as volcanoes and deep-sea trenches, relying on the "Mingyuan Project."Among the data, nearly 500 million entries are tagged with functional labels, clearly annotating the performance of proteins under specific temperatures, pH levels, and pressures.


Based on these data, Matwings Technology's general large model for protein design, AIACCLBIO®, has gradually mastered the complex mapping relationship between protein sequences and functions, and is able to optimize and modify proteins quickly and efficiently: Protein design cycle.Shortened from the traditional 2-5 years to 2-6 months, Number of experimental samplesReduced from tens of thousands to about 100, Project CostFrom tens of millions to less than millions. More importantly, the R&D success rate has also achieved a leapfrog improvement ——Traditional methods only 0.1%~1%, while AI precision design can reach 30%.


Looking ahead, Matwings Technology will continue to deepen the integration and innovation of AI and biomanufacturing, drive technological breakthroughs with intelligence, empower industrial upgrading with technology, and contribute core strength to promote the high-quality development of synthetic biology and green biomanufacturing in China.

Image

Previous Recommendations



Matwings Technology Partners with Bayer: AI-Powered Protein Design Drives Innovation in Health Consumer Products
Matwings Technology Listed | Ministry of Industry and Information Technology Announces Typical Application Cases of Artificial Intelligence in Biomanufacturing Field (First Batch)
Matwings Technology Completes Over 100 Million Yuan in Series A Financing, "Beyond Structure, Predicting Function" | Betta Pharmaceuticals Invested Company
Image
Materia MedicaResourcesThisFocused on investing in hard-core technological innovations in the globally leading life sciences sector. We allocate approximately half of our investments to Biotech, which refers to innovative pharmaceuticals, including novel drug modalities and drug discovery platforms; the other half is dedicated to TechBio, representing disruptive innovations arising from cross-disciplinary technological integration, including but not limited to IT technologies, sensors, data science, artificial intelligence, and their convergence with biology to create next-generation devices, diagnostic tools, and life science research instruments. Based in China and targeting the global market, Matwings Technology aims to advance cutting-edge progress in the life sciences field and make a positive contribution to human health and well-being.

Follow 「Herbal Capital" WeChat Official Account and set it as 'Starred ⭐' to be the first to receive the latest updates."